Gland Pharma plans Rs.70 crore capital investmentIllustrative image – not actual.

Gland Pharma plans to undertake a Rs.70 crore capital expenditure programme to diversify into biotechnology and bioinfomatics, upgrade its research and development facility and increase its production capacities for small volume parenterals and pre-filled syringes at its facility at Dundogal near Hyderabad.

 

Presently, the company has a manufacturing capacity of 12 crore vials, six crore ampoules and 1.8 crore pre-filled syringes.

← All latest storiesBack to top →